<DOC>
	<DOCNO>NCT02740179</DOCNO>
	<brief_summary>HIV-infected individual treat antiretroviral medication live longer , increase risk heart disease compare non-HIV-infected individual . A hormone call aldosterone , regulate blood pressure sodium balance , elevate HIV population association increase belly fat alter glucose metabolism . Elevations aldosterone hormone may also associate abnormal blood flow , inflammation , coronary plaque heart . This study conduct evaluate whether therapy reduce action aldosterone may decrease burden progression heart disease HIV population .</brief_summary>
	<brief_title>Effects Eplerenone Cardiovascular Disease HIV ( MIRACLE HIV Study )</brief_title>
	<detailed_description>This 12 month randomize , placebo control study enrol HIV-infected individual know history cardiovascular disease . Eplerenone mineralocorticoid receptor antagonist , block aldosterone activation . This medication approve FDA high blood pressure heart failure . This study aim investigate effect eplerenone measure cardiovascular disease HIV . Using PET , MRI , CT image technology , study evaluate whether eplerenone improve coronary flow reserve myocardial inflammation/fibrosis , addition atherosclerotic plaque build-up among HIV population . The study also include teach lifestyle modification promote healthy diet exercise program.There 3 overnight visit addition safety visit .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Mineralocorticoid Receptor Antagonists</mesh_term>
	<mesh_term>Eplerenone</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<mesh_term>Mineralocorticoids</mesh_term>
	<criteria>1 . Ages 4065 year 2 . Antiretroviral use ( ART ) &gt; 12 month HIV viral load &lt; 100 copies/mL 3 . VAT &gt; 130cm2 4 . Evidence coronary plaque coronary CTA . 1 . Antihypertensive use include , ACE Inhibitor , ARB , MR blockade , diuretic , potassium ( K ) supplementation ; BP &gt; 140/90 mmHg . Stable use ( &gt; 3 month ) betablockers calcium channel blocker ( CCB ) ( except verapamil ) allow . 2 . Statin use past 3 month . 3 . Use full dose ritonavir , nelfinavir , clarithromycin , strong inhibitiors CYP3A4 , well CYP3A4 inducer . 4 . Continuous oral steroid use ( equivalent prednisone &gt; 5 mg daily ) within last 3 month . 5 . Known diabetes , use antidiabetic medication , HbA1c &gt; 6.5 % . 6 . Creatinine ( Cr ) &gt; 1.5 mg/dL estimate GFR &lt; 60 mL/min/1.73m2 . 7 . K &gt; 5.5 mEq/L . 8 . Hemoglobin &lt; 10 g/dL . 9 . Known liver disease ALT &gt; 3x ULN . 10 . History congestive heart failure , stroke , myocardial infarction , know coronary artery disease . 11 . Pregnant , actively seek pregnancy breastfeeding . 12 . Estrogen , progestin derivative , sex steroid use within last 3 month . Stable physiologic testosterone replacement ( &gt; 3 month ) acceptable . 13 . Current bacterial infection . 14 . Active substance abuse . 15 . Significant radiation exposure course year prior randomization ( e.g. , radiation therapy , PCI , catheter ablation arrhythmia ) within 12 month randomization . 16 . Previous reaction contraindication iodinecontaining contrast medium gadolinium . 17 . Coronary artery luminal narrowing &gt; 70 % coronary CTA .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Eplerenone</keyword>
	<keyword>Cardiovascular Disease</keyword>
	<keyword>Mineralocorticoid Receptor Antagonist</keyword>
	<keyword>Coronary Vasculature</keyword>
	<keyword>Myocardial Inflammation</keyword>
	<keyword>Myocardial Fibrosis</keyword>
	<keyword>Atherosclerosis</keyword>
	<keyword>Aldosterone</keyword>
</DOC>